ENTITY
Grifols SA

Grifols SA (GRF SM)

95
Analysis
Health Care • Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullish•Grifols SA
•22 Jun 2024 05:04•Syndicated

Grifols S A (GRF/P SM) - Friday, Mar 22, 2024

Gotham City Research's short report on Grifols is seen as misguided, creating a buying opportunity for investors. Grifols is still viewed as a...

Share
x